4 citations
,
January 2017 This source reports that two noninvasive tests, the pull test and a modified wash test, can help diagnose and determine the severity of different types of hair loss in women by assessing hair shedding and characteristics, offering a simple and cost-effective evaluation method.
March 2021 in “CRC Press eBooks” This review discusses the importance of physical examinations in trichology, emphasizing their role in diagnosing conditions like alopecia and hair dystrophies, and reports no new clinical results.
January 2018 in “Hair therapy & transplantation” This study aimed to identify possible associations between a hair pull test and various pathological, biochemical, and hematological parameters in Czech patients with different types of alopecia.
January 2015 in “Springer eBooks” This chapter describes two simple, noninvasive methods — the pull test and modified wash test — which can diagnose and assess the severity of female hair loss, including conditions like telogen effluvium and androgenetic alopecia.
36 citations
,
December 2016 in “Journal of The American Academy of Dermatology” In this study, researchers evaluated the hair pull test and found that normal values should be reduced to two hairs or fewer, with no significant impact from hair washing, brushing, or lifestyle factors such as hair texture and medication use.
July 2021 in “Australasian Journal of Dermatology” This manuscript describes a proposed ‘trichoscopy-assisted hair pull test’ that enhances the diagnosis of hair loss conditions by allowing immediate examination of proximal hair shafts and roots in patients with a positive hair pull test.
4 citations
,
December 2020 in “Journal of the American Academy of Dermatology” Pulling 2 or fewer hairs is normal for all hair types, including Afro- and Asian-textured hair.
December 2023 in “Minia Journal of Medical Research” In this study, researchers found that transverse sections of alopecia areata lesions showed significantly more terminal hair follicles with perifollicular lymphocytic infiltrate compared to longitudinal sections, and this immune infiltration positively correlated with the positive hair pull test in patients.
July 2023 in “Dermatology Practical & Conceptual” This study found that a positive anagen pull test can be an indicator of lichen planopilaris activity, suggesting its utility in the clinical assessment of this condition.
11 citations
,
August 2016 in “Journal of the European Academy of Dermatology and Venereology” This letter discusses the use of serial trichoscopy versus a modified hair pull test for monitoring localized alopecia areata but reports no new clinical results.
May 2018 in “PLATELET RICH PLASMA IN ANDROGENIC ALOPECIA IN MALE AND FEMALE PATIENTS- A MYTH, A PROSPECTIVE STUDY.” 
29 citations
,
June 2013 in “Journal of the Saudi Society of Dermatology & Dermatologic Surgery” This review outlines the mechanisms, clinical features, and management strategies for alopecia areata and presents no new experimental findings.
3 citations
,
February 2008 in “Basic and clinical dermatology” Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.
1 citations
,
July 2021 in “Anais Brasileiros de Dermatologia” This study suggests that observing the acute telogen effluvium triad—frontal fringe, temporal recess, and occipital fringe—can aid in diagnosing telogen effluvium during resolution phases, despite challenges like negative pull tests.
January 2026 in “http://isrctn.com/” The food supplement may help reduce hair shedding and improve hair growth.
October 2025 in “Zenodo (CERN European Organization for Nuclear Research)” This study outlines that for addressing hair loss in young women, a comprehensive approach including hormonal evaluation, thyroid function, iron and vitamin D testing, along with clinical assessments like pull tests and trichoscopy, is recommended.
October 2025 in “Zenodo (CERN European Organization for Nuclear Research)” This study recommends a combination of hormonal and thyroid evaluations, iron studies, vitamin D testing, and clinical assessments like pull tests and trichoscopy for investigating hair loss in young women.
December 2023 in “Damianus Journal of Medicine” This study, conducted at Klinik Sukma, found no statistically significant association between COVID-19 and hair loss (telogen effluvium) despite observing that 55.6% of post-COVID patients experienced hair shedding, suggesting a 1.2 times greater risk of hair loss for these patients.
November 2023 in “International Journal of Cosmetic Science” This study found that a wheat polar lipid complex supplement significantly reduced hair loss and improved hair growth and volume in women experiencing acute hair shedding, including postmenopausal women.
This study found that DR SKS Hair Growth Booster Serum significantly reduced hair fall and improved hair density in patients with androgenic alopecia over six months, with high patient satisfaction and no major adverse events reported.
April 2016 in “Journal of The American Academy of Dermatology” A vitamin and mineral supplement significantly reduced hair shedding in Brazilian women with telogen effluvium.
July 2026 in “Bratislavské lekárske listy/Bratislava medical journal” This study found that patients with telogen effluvium who delayed hair washing or collected shed hair were more likely to have higher clinical severity and increased disease-related economic burdens, suggesting these behaviors can aid clinical assessments.
January 2025 in “MEDS Public Health and Preventive Medicine” In this study, oral spermidine supplementation was found to significantly prolong the hair follicle anagen phase and reduce hair loss, with effects persisting three months after treatment in healthy participants, suggesting potential therapeutic benefits for hair loss conditions.
This review discusses various non-invasive methods for diagnosing alopecia areata, highlighting that trichoscopy signs like short vellus hairs and yellow dots are sensitive indicators of the condition, while advanced imaging techniques provide valuable information on hair follicle status and scalp inflammation.
April 2021 in “Journal of Cosmetic Dermatology” Stem cell treatment improved hair density in female hair loss patient.
151 citations
,
August 2010 in “British Journal of Dermatology” This guideline reviews the diagnosis of androgenetic alopecia and offers expert consensus recommendations tailored to males, females, and adolescents, but reports no new clinical results.
1 citations
,
August 2021 in “Consilium Medicum” In this study, the use of Selencin, both in tablet and peptide lotion form, over two months showed significant improvements in reducing hair loss and restoring hair structure and volume in patients with diffuse alopecia, with effects persisting up to four months after treatment.
December 2021 in “Consilium Medicum” This study found that treating diffuse alopecia associated with prior COVID-19 infection using a combination of Selencin (homeopathic drug) and Selencin Peptide Active (peptide lotion) significantly reduced hair loss and improved hair structure and volume in 34 patients over two months.
45 citations
,
May 2018 in “Stem Cell Research & Therapy” In this study, patients receiving adipose-derived stromal vascular cell transplantation for alopecia areata experienced significant hair regeneration, increased growth, and improved hair quality after 3 and 6 months, indicating potential efficacy of this stem cell-based therapy for hair loss.
27 citations
,
September 2012 in “Dermatologic Clinics” This review outlines a systematic method for diagnosing hair loss and presents no new findings; the authors emphasize the importance of biopsy in cicatricial alopecia cases.